|
In the
case of ALUCAM, the aluminum production plant of the Pechiney
group (now ALCAN), the pilot study was called TRICAM (Trithérapies
Cameroun). Much courage and determination was needed then
to convince the Board that it was the corporate responsibility
to look after those contributing to the productivity and the
success of the company.
ALUCAM's
HIV program demonstrated positive impact on:
- Medical costs and productivity of employees.
- Voluntary counseling and testing which has significantly
increased.
- Social climate in the workplace.
Click
here to know how ALUCAM has overcome its challenges
and how the TRICAM results have triggered new programs
in several private companies in Cameroon and other African
countries.
HIV@MSD
was launched in April 2005. Twelve issues later, we are interested
in getting your feedback on our newsletter and website. We
would very much appreciate it if you could spare a few minutes
and answer 12 short questions in order to help us improve
its design and contents. This issue proposes a survey that
our team is conducting until March 31, 2006. in order to improve
HIV@MSD. We thank you in advance for the 2 minutes of your
time spent on answering our questions.
Click
here for the survey.
Our
mailing list has been registered with the the French Data
Protection Authority. It contains your first name, family
name and email address which shall be used only to send you
this newsletter. In accordance with articles 38 and seq. of
the French Data Privacy Law dated January 6, 1978 as amended,
you may access, modify or delete your personal information
upon request. Read our PRIVACY
NOTICE for more information.
To
remove your address from our mailing list, please UNSUBSCRIBE
|
